Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH3 | Q9ULD8 | 8/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13934337 | 0.88 | NFKB1 (0.68) | KCNH3MAPTKMT2AMEN1MAPK1 | |
| SCHEMBL14264130 | 0.85 | KCNH3 (0.51) | KCNH3MAPTKMT2AMEN1GAA | |
| SCHEMBL13852851 | 0.83 | MAPT (0.61) | KCNH3MAPTKMT2AMEN1GAA | |
| SCHEMBL633400 | 0.82 | MEN1 (0.77) | KCNH3MAPTKMT2AMEN1GAA | |
| SCHEMBL27498557 | 0.82 | BCL6 (0.57) | KCNH3MAPTKMT2AMEN1GAA | |
| SCHEMBL14972625 | 0.81 | NPC1 (0.47) | MAPTKMT2AMEN1GAAKDM4E | |
| SCHEMBL29381670 | 0.79 | SYK (0.51) | KMT2AMEN1 | |
| SCHEMBL1318576 | 0.79 | SYK (0.51) | KMT2AMEN1 | |
| SCHEMBL18123046 | 0.78 | MEN1 (0.71) | KCNH3MAPTKMT2AMEN1GAA | |
| SCHEMBL13955864 | 0.78 | KCNH3 (0.59) | KCNH3MAPTKMT2AMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8147638-B2 | Polarizing plate and display using the same | KONICA MINOLTA OPTO INC. (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20110155306-A1 | POLARIZING PLATE AND DISPLAY USING THE SAME | KONICA MINOLTA OPTO, INC. (JP) | 2011-06-30 | — | — | US | disclosed |
| US-7968019-B2 | Optical compensation film, method for producing optical compensation film, polarization plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2011-06-28 | — | — | US | disclosed |
| US-20100183529-A1 | Cosmetic compositions comprising photostabilized dibenzoylmethane compounds and 2-pyrrolidinone-4- carboxy esters | L'OREAL (FR) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100183529-A1 | Cosmetic compositions comprising photostabilized dibenzoylmethane compounds and 2-pyrrolidinone-4- carboxy esters | CYP1B1, C1S, DDT | KCNH3 1894/4885MAPT 1989/4885KMT2A 1640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.